RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on Abbott Labs (ABT – Research Report) yesterday and set a price target of $128.00. The company’s shares closed yesterday at $110.77.
According to TipRanks, Singh Chadha is an analyst with an average return of -0.8% and a 45.28% success rate. Singh Chadha covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Johnson & Johnson, and Boston Scientific.
In addition to RBC Capital, Abbott Labs also received a Buy from BTIG’s Marie Thibault in a report issued yesterday. However, on the same day, Morgan Stanley maintained a Hold rating on Abbott Labs (NYSE: ABT).
See Insiders’ Hot Stocks on TipRanks >>
Based on Abbott Labs’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $10.14 billion and a net profit of $1.44 billion. In comparison, last year the company earned a revenue of $10.41 billion and had a net profit of $1.44 billion
Based on the recent corporate insider activity of 72 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Abbott Labs (ABT) Company Description:
Abbott Laboratories offers a diversified line of healthcare products. It operates through four reportable segments: Established Pharmaceutical Products International (includes international sales of branded generic pharmaceutical products), Nutritional Products Diagnostic Products and Medical Devices. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Read More on ABT:
- Abbott (NYSE:ABT) Drops on Q4 Results
- Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
- Options Volatility and Implied Earnings Moves Today, January 24, 2024
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
